BioNexus Gene Lab Corp. Deposit Assets
BioNexus Gene Lab Corp. (BGLC) had Deposit Assets of $1.13 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › and Other Assets
us-gaap:DepositAssets · last filed 2026-08-14
- 2026-06-30: Deposit Assets $1.13M.
- 2026-03-31: Deposit Assets $1.57M.
- 2025-12-31: Deposit Assets $1.55M.
- 2025-09-30: Deposit Assets $1.54M.
| Period end | Deposit Assets |
|---|---|
| 2026-06-30 | $1.13M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.57M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $1.55M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $1.54M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $1.52M 10-Q · filed 2025-08-18 |
| 2025-03-31 | $1.51M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.49M 10-K · filed 2026-04-14 |
| 2023-12-31 | $1.41M 10-K · filed 2025-04-15 |
| 2019-06-30 | $612.14K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $615.49K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $601.00K 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |